Atlanta Clinical and Translational Science Institute (UL1)

为了响应国家努力发展，改善和提供临床和转化科学， 埃默里大学的领导层向教师和行政部门提出了挑战，要求他们改变临床和 大学及其众多组成部分和附属机构内的翻译研究。与正在进行的 在医疗保健，教育和跨学科研究的合作，埃默里大学还选择从事两个 它在亚特兰大大都市的密切学术合作伙伴-医学的莫尔豪斯学校（MSM）和格鲁吉亚 亚特兰大临床和转化科学研究所（Atlanta Clinical and Translational Science Institute） （CTSI）。这一战略性多机构联盟提供了令人信服的独特优势。埃默里 是美国领先的医疗保健和学术研究机构之一，在NIH中排名第19位 资助的研究; GA Tech是生物医学工程和创新技术应用的国家领导者 系统工程到医疗保健解决方案; MSM是一所历史上被公认为 在扩大生物医学研究的种族多样性的国家领导人，致力于社区 参与消除健康差距的努力，并作为培训少数群体的渠道 investigators.已建立的合作伙伴关系和多样化的教师队伍使亚特兰大-CTSI联合收割机强大的 埃默里大学的临床、转化、培训和基本发现项目， MSM的社区外展重点以及GA的工程和生物信息学成就 Tech.规划工作还导致了一个新的和创新的儿科临床和翻译的创建 研究计划，并与亚特兰大儿童保健的伙伴关系，新的伙伴关系， 新兴的格鲁吉亚生物技术社区和凯撒永久，以及进一步发展， 与国家赞助机构（格鲁吉亚研究联盟）和与部门的伙伴关系， 退伍军人事务部CTSI是一种旨在利用科学，技术和临床 这些机构围绕发现、培训和社区等主要目标的优势 参与创建一个新的城市范围内的家庭临床和转化研究。其他新方案 从协同合作伙伴关系产生的包括一个创新的试点项目计划PiCo-TraCS， 整合临床互动和生物医学信息学网络（CIN和BIN），创建一种技术 “管道”和转化方法开发学院，一个生物信息学跨越式倡议，一个 促进人类研究办公室，创造性的K30/K12和T32计划，以及一个杰出的 社区参与计划。对该中心的机构支持是特殊的。亚特兰大- CTSI利用埃默里大学，MSM和GA技术和其他GA机构的互补优势， 促进临床和转化科学的学科，并改善我们社区的医疗保健。

In response to the national effort to develop, improve, and deliver clinical and translational science, the leadership of Emory University challenged both faculty and the administration to transform clinical and translational research within the University and its numerous components and affiliates. With ongoing collaborations in heath-care, education, and interdisciplinary research, Emory also chose to engage two of its close academic partners in metropolitan Atlanta - Morehouse School of Medicine (MSM) and Georgia Institute of Technology (GA Tech) to form the Atlanta Clinical and Translational Science Institute (Atlanta-CTSI). This strategic multi-institutional alliance offered compelling and unique advantages. Emory is one of the nation's leading healthcare and academic research institutions, ranking 19th nationally in NIH funded research; GA Tech is a national leader in biomedical engineering and the application of innovative systems engineering to health care solutions; and MSM is a historically black medical school recognized as a national leader in expanding the ethnic diversity of biomedical research, dedicated to community engagement in efforts to eliminate health disparities and serving as a pipeline for training minority investigators. The established partnerships and diverse faculty enable the Atlanta-CTSI to combine strong clinical, translational,training and basic discovery programs at Emory with the health disparities, training and community outreach focus of MSM together with the engineering and bioinformatics achievements of GA Tech. The planning efforts also led to the creation of a new and innovative pediatric clinical and translational research program and a partnership with Children's Healthcare of Atlanta, new partnerships with the emerging Georgia biotechnology community and with Kaiser Permanente, and the further development of partnerships with state sponsored agencies (Georgia Research Alliance) and with the Department of Veterans Affairs. The Atlanta-CTSI is a model designed to harness the scientific, technological, and clinical advantages of these institutions around the major aims of discovery, training, and community engagement to create a new city wide home for clinical and translational research. Other new programs resulting from the synergistic partnership include an innovative pilot projects program PiCo-TraCS, integrated clinical interactions and biomedical informatics networks (CIN and BIN), creation of a technology "pipeline" andAcademy for Translational Methods Development, a bioinformatics Leapfrog initiative, a facilitating Office of Human Studies Research, creative K30/K12 and T32 programs, and an outstanding community engagement program. The institutional support for the Atlanta-CTSI is exceptional. The Atlanta- CTSI utilizes the complementary strengths of Emory, MSM, and GA Tech and other GA institutions to promote the discipline of clinical and translational science and to improve the healthcare of our community.